These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 28379375)

  • 1. Clinical, Serological, and Virological Analysis of 572 Chikungunya Patients From 2010 to 2013 in India.
    Jain J; Nayak K; Tanwar N; Gaind R; Gupta B; Shastri JS; Bhatnagar RK; Kaja MK; Chandele A; Sunil S
    Clin Infect Dis; 2017 Jul; 65(1):133-140. PubMed ID: 28379375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of chikungunya virus infection in children from India during 2009-2010: A cross sectional observational study.
    Raghavendhar BS; Ray P; Ratagiri VH; Sharma BS; Kabra SK; Lodha R
    J Med Virol; 2016 Jun; 88(6):923-30. PubMed ID: 26581026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of plasma viral loads and presence of Chikungunya IgM antibodies with cytokine/chemokine levels during acute Chikungunya virus infection.
    Reddy V; Mani RS; Desai A; Ravi V
    J Med Virol; 2014 Aug; 86(8):1393-401. PubMed ID: 24523146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-emergence of Chikungunya virus infection in Eastern India.
    Sengupta S; Mukherjee S; Haldar SK; Bhattacharya N; Tripathi A
    Braz J Microbiol; 2020 Mar; 51(1):177-182. PubMed ID: 31898249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copy number variation of Chikungunya ECSA virus with disease symptoms among Indian patients.
    Dutta SK; Pal T; Saha B; Mandal S; Tripathi A
    J Med Virol; 2014 Aug; 86(8):1386-92. PubMed ID: 24132555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chikungunya Outbreaks in India: A Prospective Study Comparing Neutralization and Sequelae during Two Outbreaks in 2010 and 2016.
    Jain J; Kaur N; Haller SL; Kumar A; Rossi SL; Narayanan V; Kumar D; Gaind R; Weaver SC; Auguste AJ; Sunil S
    Am J Trop Med Hyg; 2020 Apr; 102(4):857-868. PubMed ID: 32067624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory surveillance of chikungunya in Madhya Pradesh, India (2016-2017).
    Joshi P; Yadav P; Mourya D; Sahare L; Ukey M; Khedekar R; Patil D; Barde PV
    Indian J Med Res; 2020 Jan; 151(1):87-92. PubMed ID: 32134019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hidden burden of chikungunya in North India; A prospective study in a tertiary care centre.
    Dinkar A; Singh J; Prakash P; Das A; Nath G
    J Infect Public Health; 2018; 11(4):586-591. PubMed ID: 28993172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chikungunya Virus Seroprevalence and Associated Factors among Hospital Attendees in Two States of Southwest Nigeria: A Preliminary Assessment.
    Olajiga OM; Adesoye OE; Emilolorun AP; Adeyemi AJ; Adeyefa EO; Aderibigbe IA; Adejumo SA; Adebimpe WO; Opaleye OO; Sule WF; Oluwayelu DO
    Immunol Invest; 2017 Aug; 46(6):552-565. PubMed ID: 28742401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chikungunya infection in India: results of a prospective hospital based multi-centric study.
    Ray P; Ratagiri VH; Kabra SK; Lodha R; Sharma S; Sharma BS; Kalaivani M; Wig N
    PLoS One; 2012; 7(2):e30025. PubMed ID: 22363413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of dengue and chikungunya virus strains circulating in New Delhi, India.
    Afreen N; Deeba F; Khan WH; Haider SH; Kazim SN; Ishrat R; Naqvi IH; Shareef MY; Broor S; Ahmed A; Parveen S
    Microbiol Immunol; 2014 Dec; 58(12):688-96. PubMed ID: 25346397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single dose of ChAdOx1 Chik vaccine induces neutralizing antibodies against four chikungunya virus lineages in a phase 1 clinical trial.
    Folegatti PM; Harrison K; Preciado-Llanes L; Lopez FR; Bittaye M; Kim YC; Flaxman A; Bellamy D; Makinson R; Sheridan J; Azar SR; Campos RK; Tilley M; Tran N; Jenkin D; Poulton I; Lawrie A; Roberts R; Berrie E; Rossi SL; Hill A; Ewer KJ; Reyes-Sandoval A
    Nat Commun; 2021 Jul; 12(1):4636. PubMed ID: 34330906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating the seroprevalence of chikungunya virus exposure in Shimoga district, Karnataka state: A hospital-based study during 2014-2018.
    Shilpa C; Kavitha K; Sudheesh N; Sabeena S; Prasad V; Hindol M; Arunkumar G
    J Med Virol; 2020 Jan; 92(1):119-123. PubMed ID: 31463940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-existing chikungunya virus neutralizing antibodies correlate with risk of symptomatic infection and subclinical seroconversion in a Philippine cohort.
    Yoon IK; Srikiatkhachorn A; Alera MT; Fernandez S; Cummings DAT; Salje H
    Int J Infect Dis; 2020 Jun; 95():167-173. PubMed ID: 32247051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chikungunya virus RNA and antibody testing at a National Reference Laboratory since the emergence of Chikungunya virus in the Americas.
    Prince HE; Seaton BL; Matud JL; Batterman HJ
    Clin Vaccine Immunol; 2015 Mar; 22(3):291-7. PubMed ID: 25540275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of Chikungunya dominated co-infection with dengue during an outbreak in south India (2010 and 2012).
    Venkatasubramani K; Paramasivan R; Thenmozhi V; Dhananjeyan KJ; Balaji T; Leo SV
    Trop Doct; 2015 Jul; 45(3):197-9. PubMed ID: 25990548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody response patterns in chikungunya febrile phase predict protection versus progression to chronic arthritis.
    Nayak K; Jain V; Kaur M; Khan N; Gottimukkala K; Aggarwal C; Sagar R; Gupta S; Rai RC; Dixit K; Islamuddin M; Khan WH; Verma A; Maheshwari D; Chawla YM; Reddy ES; Panda H; Sharma P; Bhatnagar P; Singh P; Raghavendhar B S; Patel AK; Ratageri VH; Chandele A; Ray P; Murali-Krishna K
    JCI Insight; 2020 Apr; 5(7):. PubMed ID: 32155134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-Dependent Evaluation of Immunoglobulin G Response after Chikungunya Virus Infection.
    Patil HP; Gosavi M; Mishra AC; Arankalle VA
    Am J Trop Med Hyg; 2021 Feb; 104(4):1438-1443. PubMed ID: 33617471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent arthralgia among Chikungunya patients and associated risk factors in Chennai, South India.
    Ramachandran V; Kaur P; Kanagasabai K; Vadivoo S; Murhekar MV
    J Postgrad Med; 2014; 60(1):3-6. PubMed ID: 24625931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease Resolution in Chikungunya-What Decides the Outcome?
    Srivastava P; Kumar A; Hasan A; Mehta D; Kumar R; Sharma C; Sunil S
    Front Immunol; 2020; 11():695. PubMed ID: 32411133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.